Literature DB >> 8546681

Activation of human liver 3 alpha-hydroxysteroid dehydrogenase by sulphobromophthalein.

K Matsuura1, Y Tamada, Y Deyashiki, Y Miyabe, M Nakanishi, I Ohya, A Hara.   

Abstract

Human liver contains at least two isoenzymes (DD2 and DD4) of 3 alpha-hydroxysteroid/dihydrodiol dehydrogenase. The NADP(H)-linked oxidoreductase activities of DD4 were activated more than 4-fold by sulphobromophthalein at concentrations above 20 microM and under physiological pH conditions. Sulphobromophthalein did not stimulate the activities of DD2 and human liver aldehyde reductase, which are functionally and/or structurally related to DD4. No stimulatory effect on the activity of DD4 was observed with other organic anions such as Indocyanine Green, haematin and Rose Bengal. The binding of sulphobromophthalein to DD4 was instantaneous and reversible, and was detected by fluorescence and ultrafiltration assays. The activation by sulphobromophthalein decreased the activation energy in the dehydrogenation reaction for the enzyme, and increased both kcat, and Km values for the coenzymes and substrates. Kinetic analyses with respect to concentrations of NADP+ and (S)-(+)-indan-1-ol indicated that sulphobromophthalein was a non-essential activator of mixed type showing a dissociation constant of 2.6 microM. Thus, the human 3 alpha-hydroxysteroid dehydrogenase isoenzyme has a binding site specific to sulphobromophthalein, and the hepatic metabolism mediated by this isoenzyme may be influenced when this drug is administered.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8546681      PMCID: PMC1216880          DOI: 10.1042/bj3130179

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  31 in total

1.  The kinetics of enzyme-catalyzed reactions with two or more substrates or products. I. Nomenclature and rate equations.

Authors:  W W CLELAND
Journal:  Biochim Biophys Acta       Date:  1963-01-08

2.  Relationship between the newly identified bile acid binder and bile acid oxidoreductases in human liver.

Authors:  H Takikawa; A Stolz; Y Sugiyama; H Yoshida; M Yamanaka; N Kaplowitz
Journal:  J Biol Chem       Date:  1990-02-05       Impact factor: 5.157

Review 3.  Aldose reductase catalysis and crystallography. Insights from recent advances in enzyme structure and function.

Authors:  J M Petrash; I Tarle; D K Wilson; F A Quiocho
Journal:  Diabetes       Date:  1994-08       Impact factor: 9.461

4.  Overexpression and mutagenesis of the cDNA for rat liver 3 alpha-hydroxysteroid/dihydrodiol dehydrogenase. Role of cysteines and tyrosines in catalysis.

Authors:  J E Pawlowski; T M Penning
Journal:  J Biol Chem       Date:  1994-05-06       Impact factor: 5.157

5.  Three-dimensional structure of rat liver 3 alpha-hydroxysteroid/dihydrodiol dehydrogenase: a member of the aldo-keto reductase superfamily.

Authors:  S S Hoog; J E Pawlowski; P M Alzari; T M Penning; M Lewis
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

6.  Reduction of prostaglandin D2 to 9 alpha,11 beta-prostaglandin F2 by a human liver 3 alpha-hydroxysteroid/dihydrodiol dehydrogenase isozyme.

Authors:  H Ohara; T Nakayama; Y Deyashiki; A Hara; Y Miyabe; F Tsukada
Journal:  Biochim Biophys Acta       Date:  1994-11-17

7.  Expression and kinetic properties of a recombinant 3 alpha-hydroxysteroid/dihydrodiol dehydrogenase isoenzyme of human liver.

Authors:  Y Deyashiki; Y Tamada; Y Miyabe; M Nakanishi; K Matsuura; A Hara
Journal:  J Biochem       Date:  1995-08       Impact factor: 3.387

8.  Molecular cloning and characterization of mouse estradiol 17 beta-dehydrogenase (A-specific), a member of the aldoketoreductase family.

Authors:  Y Deyashiki; K Ohshima; M Nakanishi; K Sato; K Matsuura; A Hara
Journal:  J Biol Chem       Date:  1995-05-05       Impact factor: 5.157

9.  An anion binding site in human aldose reductase: mechanistic implications for the binding of citrate, cacodylate, and glucose 6-phosphate.

Authors:  D H Harrison; K M Bohren; D Ringe; G A Petsko; K H Gabbay
Journal:  Biochemistry       Date:  1994-03-01       Impact factor: 3.162

10.  Reduction of drug ketones by dihydrodiol dehydrogenases, carbonyl reductase and aldehyde reductase of human liver.

Authors:  H Ohara; Y Miyabe; Y Deyashiki; K Matsuura; A Hara
Journal:  Biochem Pharmacol       Date:  1995-07-17       Impact factor: 5.858

View more
  4 in total

1.  Kinetic alteration of a human dihydrodiol/3alpha-hydroxysteroid dehydrogenase isoenzyme, AKR1C4, by replacement of histidine-216 with tyrosine or phenylalanine.

Authors:  T Ohta; S Ishikura; S Shintani; N Usami; A Hara
Journal:  Biochem J       Date:  2000-12-15       Impact factor: 3.857

2.  Involvement of two basic residues (Lys-270 and Arg-276) of human liver 3 alpha-hydroxysteroid dehydrogenase in NADP(H) binding and activation by sulphobromophthalein: site-directed mutagenesis and kinetic analysis.

Authors:  K Matsuura; Y Tamada; K Sato; H Iwasa; G Miwa; Y Deyashiki; A Hara
Journal:  Biochem J       Date:  1997-02-15       Impact factor: 3.857

3.  Roles of the C-terminal domains of human dihydrodiol dehydrogenase isoforms in the binding of substrates and modulators: probing with chimaeric enzymes.

Authors:  K Matsuura; A Hara; Y Deyashiki; H Iwasa; T Kume; S Ishikura; H Shiraishi; Y Katagiri
Journal:  Biochem J       Date:  1998-12-01       Impact factor: 3.857

4.  Induction and repression of peroxisome proliferator-activated receptor alpha transcription by coregulator ARA70.

Authors:  Cynthia A Heinlein; Chawnshang Chang
Journal:  Endocrine       Date:  2003-07       Impact factor: 3.633

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.